BioSpace News Archive

Epizyme, Inc. announced that management will host a conference call and webcast to discuss its second quarter 2020 financial results and other business highlights and will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference.

LabCorp announced results for the second quarter ended June 30, 2020.

Plus Therapeutics, Inc. announced the successful completion of the fifth cohort of the ReSPECT Clinical Trial and expansion to a second clinical trial site, the UT Southwestern Medical Center in Dallas.

Sol-Gel Technologies, Ltd., a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, announced that Sol-Gel has been informed by its collaboration partner that the launch of an FDA-approved generic drug is expected in the second quarter of 2021.

Protara Therapeutics, Inc., a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, announced that the U.S.

Dr. Marchand and The Marchand Institute for Minimally Invasive Surgery were awarded a patent for the “Marchand Salpingectomy,” a surgical technique used for removing the fallopian tubes in a woman who desires sterilization.

Ortho Regenerative Technologies Inc., an emerging orthobiologics company, announced new positive results following completion of its pivotal preclinical study report in Rotator Cuff Tear repair under Good Laboratory Practices conditions.

Acorda Therapeutics, Inc. will host a conference call and webcast in conjunction with its second quarter 2020 update and financial results on Tuesday, August 4 at 4:30 p.m.

FARXIGA significantly reduced the worsening of renal function or risk of death in patients with chronic kidney disease with and without type 2 diabetes

Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will host a conference call with members of Strongbridge’s management team on Tuesday, August 4 at 8:30 a.m. ET to discuss the Company’s second quarter 2020 financial results and to provide a business